Skip to main content
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · IEX Real-Time Price · USD
5.60
-0.01 (-0.18%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $200.79M in the twelve months ending March 31, 2024, with 20.91% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $44.86M with 20.96% year-over-year growth. In the year 2023, Cytek Biosciences had annual revenue of $193.02M with 17.67% growth.

Revenue (ttm)
$200.79M
Revenue Growth
+20.91%
P/S Ratio
3.66
Revenue / Employee
$297,021
Employees
676
Market Cap
735.13M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Pennant Group 575.34M
CareDx 275.11M
Aurinia Pharmaceuticals 191.41M
CureVac 64.13M
Mesoblast 7.25M
Perspective Therapeutics -304.00K
Revenue Rankings

CTKB News

More News